Publication | Closed Access
Novel second generation analogs of eribulin. Part II: Orally available and active against resistant tumors in vivo
19
Citations
9
References
2011
Year
Tumor BiologyMedicinePharmacologyPharmacotherapyAnti-cancer AgentTumor TargetingResistant TumorsCancer TreatmentOncologyRadiation OncologyNovel TherapyCancer ResearchDrug DiscoveryPart Ii
| Year | Citations | |
|---|---|---|
Page 1
Page 1